WHO says monkeypox cases triple in Europe in two weeks, urgent action needed to contain spread

WHO says monkeypox cases triple in Europe in two weeks, urgent action needed to contain spread


The World Health Organization on Friday warned that urgent action is needed to contain the spread of monkeypox in Europe, as cases have tripled over the past two weeks.

Europe is the center of a global outbreak of the virus with 90% of confirmed monkeypox cases reported there, according to the WHO. New infections have tripled since June 15 with 4,500 confirmed cases across 31 European nations.

Henri Kluge, the head of WHO Europe, called on governments to ramp efforts to prevent monkeypox from establishing itself on the continent, warning that time is of the essence.

“Urgent and coordinated action is imperative if we are to turn a corner in the race to reverse the ongoing spread of this disease,” Kluge said.

The World Health Organization on Saturday declined to declare monkeypox a public health emergency of international concern, its highest alert level. However, WHO chief Tedros Adhanom Ghebreyesus said monkeypox is an evolving health threat. Tedros called on governments to step up surveillance, contact tracing and to make sure people at high risk have access to vaccines and antivirals.

Kluge said the WHO will likely reconsider whether monkeypox is global health emergency soon, given the “rapid evolution and emergency nature of the event.” He said 99% of monkeypox patients in Europe are men between the ages of 21 and 40. The majority of the patients who provided demographic information identified as men who have sex with men, he said.

Monkeypox primarily spreads through close physical contact with much of the transmission in the current outbreak happening through sex. However, small numbers of cases have now been reported in which the patients did not catch the virus during sexual contact, Kluge said. Family members of infected individuals, heterosexual contacts as well as children have also caught the virus, he said.

Among patients where information was available on their status, nearly 10% were hospitalized for treatment or isolation and one patient ended up in an intensive care unit, Kluge said. Nobody in Europe has died so far from the virus, he said.

“There is simply no room for complacency – especially right here in the European Region with its fast-moving outbreak that with every hour, day and week is extending its reach into previously unaffected areas,” Kluge said.

The stigmatization of men who have sex with men in some countries has made it difficult to get a full picture of the outbreak, Kluge said. Some people with monkeypox symptoms might avoid going to health-care providers for a diagnosis because they are fearful of consequences if someone finds out they are gay or bisexual, Kluge said. However, clearly communicating the reality of the current outbreak is also crucial, he added.

“We know from our lessons in dealing with HIV how stigma further fuels outbreaks and epidemics, but allowing our fear of creating stigma to prevent us from acting may be just as damaging,” Kluge said.

Kluge said public health authorities in Europe must quickly ramp up surveillance for monkeypox and their capacity to diagnose the disease and sequence samples. Contacts of people who have monkeypox also need to be quickly identified to stop the spread, he said.

Public health authorities also need to get the word out among high risk communities and the wider public about what precautions to take when attending mass gatherings this summer, Kluge said. And vaccines need to be distributed in equitable manner with a focus on those most at risk, he added.

Monkeypox primarily spreads through close physical contact with a person who is infected or contaminated material such as shared clothing or bedsheets. The virus can spread through respiratory droplets if an infected person has lesions in their throat or mouth. That requires sustained face-to-face contact, however. Monkeypox is not believed to spread through aerosol particles like Covid-19.

Respiratory droplets fall to the ground quickly, while aerosol particles linger in the air for a longer period of time, which is one of the reasons Covid is so contagious.

Monkeypox is in the same virus family as smallpox, but it has milder symptoms. Most people recover in two to four weeks without specific medical treatment.

Monkeypox often begins with symptoms similar to the flu, such as fever, headache, soar throat, body aches, chills, exhaustion, diarrhea and swollen lymph nodes. A rash that looks like pimples or blisters then appears on the body. People are most infectious when they have the rash.

Kluge said the vast majority of patients in Europe had a rash and about three-quarters reported flulike symptoms.

Some patients in the current outbreak have developed a rash only on the genitals or anus before showing any flulike symptoms, according to the U.S. Centers for Disease Control and Prevention. In other cases, patients developed the rash without any flulike symptoms at all.



Source

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 
Health

Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows 

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual care company Omada Health on Thursday said it will start prescribing GLP-1s and other obesity drugs and helping patients manage those medications. Omada plans to expand the offerings under its weight management program as its membership grows […]

Read More
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Health

Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming […]

Read More
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 
Health

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 

Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, called eloralintide, helped patients […]

Read More